Diagnostic characteristics of anti-endomysial antibody in the diagnosis of celiac disease—A multicenter prospective observational study
Indian Journal of Pathology and Microbiology · 2026-07 · 69 (3) · 460-464
DOI: 10.4103/ijpm.ijpm_1027_25 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Indian Journal of Pathology and Microbiology, online erschienen am 25.07.2026. Verfasst von Alka Kumari und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, Delhi, India. Hauptthemen laut MEDLINE: Celiac Disease, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Anti-endomysial antibody (EMA) has demonstrated high specificity and reasonable sensitivity for the diagnosis of celiac disease (CeD). We aimed to evaluate the diagnostic accuracy of EMA in our patients with CeD. Materials and Methods: In this prospective study, we included patients of treatment-naïve CeD as cases who were recruited under an Indian National CeD Biorepository and had already tested positive for IgA anti-tTG, hence diagnosed as CeD based on standard criteria. Patients with other enteropathies, functional dyspepsia and gastroesophageal reflux disease, in whom IgA anti-tTG was negative, were taken as controls. Both cases and controls underwent testing for EMA using an immunofluorescence-based assay (Inova Diagnostic, USA). Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated.
Results
The mean age of patients with CeD and controls was 28.3 ± 12.2 and 35.5 ± 10.72, respectively ( P < 0.001). EMA was positive in only 50.9% (141 of 277) patients with CeD, while in the control group, 1 out of 90 (1.1%) had positive EMA. The sensitivity, specificity, PPV, and NPV were 50.9, 98.9, 99.3, and 39.6%, respectively. Diagnostic odds ratio, positive LR, and negative LR were 92.3, 45.8, and 0.49, respectively.
Conclusion
EMA test has high specificity and low sensitivity. Only half of adult CeD patients had positive EMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, Delhi, India.
- Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
- Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Zitieren
APA
Kumari, A., Pachisia, A. V., Kumar, S., Sharma, D., Ahmed, A., Sharma, S., Chauhan, A., Dutta, R., Das, P., Falodia, S., Sinha, S. K., Ahuja, V., & Makharia, G. K. (2026). Diagnostic characteristics of anti-endomysial antibody in the diagnosis of celiac disease—A multicenter prospective observational study. Indian Journal of Pathology and Microbiology, 69(3), 460-464. https://doi.org/10.4103/ijpm.ijpm_1027_25
Vancouver
Kumari A, Pachisia AV, Kumar S, Sharma D, Ahmed A, Sharma S, et al. Diagnostic characteristics of anti-endomysial antibody in the diagnosis of celiac disease—A multicenter prospective observational study. Indian Journal of Pathology and Microbiology. 2026;69(3):460-464. doi:10.4103/ijpm.ijpm_1027_25
BibTeX
@article{Kumari2026,
author = {Kumari, Alka and Pachisia, Aditya V and Kumar, Sanjay and Sharma, Divya and Ahmed, Anam and Sharma, Sonu and Chauhan, Ashish and Dutta, Rimlee and Das, Prasenjit and Falodia, Sushil and Sinha, Saroj K and Ahuja, Vineet and Makharia, Govind K},
title = {Diagnostic characteristics of anti-endomysial antibody in the diagnosis of celiac disease—A multicenter prospective observational study},
journal = {Indian Journal of Pathology and Microbiology},
year = {2026},
volume = {69},
number = {3},
pages = {460--464},
doi = {10.4103/ijpm.ijpm_1027_25}
}
EUVIMED